Erratum: Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: A role for the novel interaction of alpha-synuclein and presenilin 1 in disease (Brain (2014) 137 (1958-1970) DOI: 10.1093/brain/awu119);Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: A role for the novel interaction of alpha-synuclein and presenilin 1 in disease

Brain

Volumn 137, Issue 7, 2014, Pages 1958-1970

  Winslow, Ashley R ^a   Moussaud, Simon ^b   Zhu, Liya ^a   Post, Katherine L ^a   Dickson, Dennis W ^b   Berezovska, Oksana ^a   McLean, Pamela J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

ageing; Alzheimer's disease; dementia; Lewy body; Parkinson's disease; presenilin; synuclein

Indexed keywords

ALPHA SYNUCLEIN; GAMMA SECRETASE; GLUTATHIONE TRANSFERASE; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CONTROLLED STUDY; CROSS LINKING; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; MALE; MASS SPECTROMETRY; MOUSE; NERVE CELL CULTURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

AGEING; ALZHEIMER'S DISEASE; DEMENTIA; LEWY BODY; PARKINSON'S DISEASE; PRESENILIN; Α-SYNUCLEIN;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BRAIN; CELLS, CULTURED; CEREBRAL CORTEX; CHO CELLS; CRICETULUS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; LEWY BODY DISEASE; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, IMMUNOELECTRON; MUTATION; NEURONS; PRESENILIN-1;

EID: 84903546368     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu208     Document Type: Erratum

References (50)

1. Berezovska O, Ramdya P, Skoch J, Wolfe MS, Bacskai BJ, et al. Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neurosci 2003; 23: 4560-6. (Pubitemid 36706186)
2. Berezovska O, Lleo A, Herl LD, Frosch MP, Stern EA, Bacskai BJ, et al. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 2005; 25: 3009-17. (Pubitemid 40389259)
3. Bodner CR, Dobson CM, Bax A. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J Mol Biol 2009; 390: 775-90.
4. Bonner LT, Tsuang DW, Cherrier MM, Eugenio CJ, Du Jennifer Q, Steinbart EJ, et al. Familial dementia with Lewy bodies with an atypical clinical presentation. J Geriatr Psychiatry Neurol 2003; 16: 59-64. (Pubitemid 37408292)
5. Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology. Arch Neurol 2002; 59: 464-7. (Pubitemid 34208158)
6. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010; 329: 1663-7.
7. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005; 123: 383-96. (Pubitemid 41546670)
8. Chen RH, Wislet-Gendebien S, Samuel F, Visanji NP, Zhang G, Marsilio D, et al. alpha-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J Biol Chem 2013; 288: 7438-49.
9. Choi BK, Choi MG, Kim JY, Yang Y, Lai Y, Kweon DH, et al. Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc Natl Acad Sci USA 2013; 110: 4087-92.
10. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006; 313: 324-8. (Pubitemid 44480951)
11. Denson MA, Wszolek ZK, Pfeiffer RF, Wszolek EK, Paschall TM, McComb RD. Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol 1997; 42: 638-43. (Pubitemid 27439027)
12. Efthimiopoulos S, Floor E, Georgakopoulos A, Shioi J, Cui W, Yasothornsrikul S, et al. Enrichment of presenilin 1 peptides in neuronal large dense-core and somatodendritic clathrin-coated vesicles. J Neurochem 1998; 71: 2365-72. (Pubitemid 28531246)
13. Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 2004; 24: 6715-23. (Pubitemid 38993891)
14. Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA 2008; 105: 145-50.
15. Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, et al. SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Gen Physiol 2008; 132: i1.
16. Guardia-Laguarta C, Area-Gomez E, Rub C, Liu Y, Magrane J, Becker D, et al. alpha-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 2014; 34: 249-59.
17. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, et al. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol Chem 2004; 279: 51654-60. (Pubitemid 40017916)
18. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B. Total inactivation of gamma-secretase activity in presenilin- deficient embryonic stem cells. Nat Cell Biol 2000; 2: 461-2.
19. Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E. Neuropathology of dementia in a large cohort of patients with Parkinson's disease. Parkinsonism Relat Disord 2013; 19: 864-8.
20. Ishikawa A, Piao YS, Miyashita A, Kuwano R, Onodera O, Ohtake H, et al. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease. Ann Neurol 2005; 57: 429-34. (Pubitemid 40343966)
21. Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, et al. Soluble alpha-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci 2012; 32: 10253-66.
22. Lee HJ, Choi C, Lee SJ. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 2002; 277: 671-8. (Pubitemid 34952106)
23. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010; 141: 1146-58.
24. Leftin A, Job C, Beyer K, Brown MF. Solid-State C NMR reveals annealing of raft-like membranes containing cholesterol by the intrinsically disordered protein alpha-synuclein. J Mol Biol 2013; 425: 2973-87.
25. Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, et al. Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006; 63: 370-6.
26. Lionaki E, Tavernarakis N. Oxidative stress and mitochondrial protein quality control in aging. J Proteomics 2013; 92: 181-94.
27. Lleo A, Berezovska O, Herl L, Raju S, Deng A, Bacskai BJ, et al. Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med 2004; 10: 1065-6. (Pubitemid 39424866)
28. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3: 19-28. (Pubitemid 38018924)
29. Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, et al. DLB and PDD: a role for mutations in dementia and Parkinson disease genes? Neurobiol Aging 2012; 33: 629 e5-629 e18.
30. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 2000; 20: 3214-20. (Pubitemid 30263139)
31. Murshid A, Eguchi T, Calderwood SK. Stress proteins in aging and life span. Int J Hyperthermia 2013; 29: 442-7.
32. Nervi A, Reitz C, Tang MX, Santana V, Piriz A, Reyes D, et al. Familial aggregation of dementia with Lewy bodies. Arch Neurol 2011; 68: 90-3.
33. Ohara K, Takauchi S, Kokai M, Morimura Y, Nakajima T, Morita Y. Familial dementia with Lewy bodies (DLB). Clin Neuropathol 1999; 18: 232-9. (Pubitemid 29422203)
34. Ohta K, Mizuno A, Ueda M, Li S, Suzuki Y, Hida Y, et al. Autophagy impairment stimulates PS1 expression and gamma-secretase activity. Autophagy 2010; 6: 345-52.
35. Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, et al. Formation of toxic oligomeric alpha-synuclein species in living cells. PloS One 2008; 3: e1867.
36. Pranke IM, Morello V, Bigay J, Gibson K, Verbavatz JM, Antonny B, et al. alpha-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J Cell Biol 2011; 194: 89-103.
37. Putcha P, Danzer KM, Kranich LR, Scott A, Silinski M, Mabbett S, et al. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha- synuclein oligomer formation and rescue alpha-synuclein-induced toxicity. J Pharmacol Exper Therapeutics 2010; 332: 849-57.
38. Remy I, Michnick SW. A cDNA library functional screening strategy based on fluorescent protein complementation assays to identify novel components of signaling pathways. Methods 2004; 32: 381-8. (Pubitemid 38299329)
39. Remy I, Michnick SW. A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods 2006; 3: 977-9. (Pubitemid 44782695)
40. Scott D, Roy S. alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J Neurosci 2012; 32: 10129-35.
41. Smith AL, Friedman DB, Yu H, Carnahan RH, Reynolds AB. ReCLIP (reversible cross-link immuno-precipitation): an efficient method for interrogation of labile protein complexes. PloS One 2011; 6: e16206.
42. Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol 2005; 62: 1821-30. (Pubitemid 41785075)
43. Torp R, Ottersen OP, Cotman CW, Head E. Identification of neuronal plasma membrane microdomains that colocalize beta-amyloid and presenilin: implications for beta-amyloid precursor protein processing. Neuroscience 2003; 120: 291-300. (Pubitemid 37288767)
44. Tsakiri EN, Sykiotis GP, Papassideri IS, Gorgoulis VG, Bohmann D, Trougakos IP. Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. FASEB J 2013; 27: 2407-20.
45. Tsuang DW, DiGiacomo L, Bird TD. Familial occurrence of dementia with Lewy bodies. Am J Geriatr Psychiatry 2004; 12: 179-88. (Pubitemid 38250301)
46. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2 + leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006; 126: 981-93. (Pubitemid 44310781)
47. Vamvaca K, Volles MJ, Lansbury PT Jr. The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast. J Mol Biol 2009; 389: 413-24.
48. Wahlster L, Arimon M, Nasser-Ghodsi N, Post KL, Serrano-Pozo A, Uemura K, et al. Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease. Acta Neuropathol 2013; 125: 187-99.
49. Wang CH, Wu SB, Wu YT, Wei YH. Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging. Exp Biol Med 2013; 238: 450-60.
50. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 1994; 35: 59-64. (Pubitemid 24027607)